Trials / Conditions / Anti-PD1 Antibody
Anti-PD1 Antibody
3 registered clinical trials studyying Anti-PD1 Antibody — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma NCT06740370 | Sun Yat-sen University | N/A |
| Recruiting | Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma NCT06550921 | Sun Yat-sen University | N/A |
| Completed | Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma NCT04627012 | Sun Yat-sen University | — |